Page 21 - நிறுவன பங்குதாரர் சேவைகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Malvern-based Recro Pharma prices $30M public stock sale - Philadelphia Business Journal
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Shaw Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote for the Proposed Business Combination With Rogers
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
FSD Pharma files New Animal Drug Application with FDA for FSD201 to treat gastrointestinal enteropathy in dogs
The proposed design is a randomized and double-blind trial of 200 dogs that will compare FSD201 dosed twice daily to a placebo for the treatment of canine inflammatory bowel disease FSD Pharma said the primary endpoint will be a validated diarrhea score, evaluated by both the treating veterinarian and the dog owner
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) said it has submitted to the US Food and Drug Administration an Investigational New Animal Drug Application (IND) for the use of FSD201 to treat gastrointestinal enteropathy in dogs.
Alphamin, CIBC, Chartwell at 52-Week Highs on News Alphamin Resources Corp. (V.AFM) hit a new 52-week high of 68 cents on Friday. Alphamin announced Record Q1 EBITDA of $36,5m , at a tin price of $23,083/t (Current: ~$29,000/t.
Canadian Imperial Bank of Commerce (T.CM) hit a new 52-week high of $130.79 on Friday. CIBC has outperformed much of the Canadian banking sector due to the resilience of its underlying business. A cost-to-income ratio of 54.9% in Q1 2021 reflects improvement in its operational efficiency.The economic recovery and a strong capital markets outlook should drive further growth in near-term earnings.
Chartwell Retirement Residences (T.CSH.UN) hit a new 52-week high of $12.97 on Friday. Chartwell announces that Institutional Shareholder Services Inc. (“ISS”), an independent proxy advisory firm that provides voting recommendations to shareholders, has issued a positive review of the Company s key resolutions relating to their upcoming Annual Me
Search jobs 05-May-2021 FSD Pharma Announces That ISS Recommends Shareholders Vote for the Company’s Nominees to the Board Using Only the BLUE Proxy
Shareholders URGED to Vote the BLUE proxy by 9:00 a.m. on May 12, 2021
TORONTO (BUSINESS WIRE) $HUGE FSD Pharma Inc. (the “Company”) today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent international corporate governance analysis and proxy advisory firm, has recommended that shareholders vote FOR all Company Director Nominees (the Management Director Nominees ) in a contested election for the Board of Directors and FOR the elimination of the dual-class share structure (the Dual-Class Sunset ) at the annual and special meeting of shareholders on May 14, 2021 (the Meeting ).
vimarsana © 2020. All Rights Reserved.